Amplified immune response by ginsenoside-based nanoparticles (ginsomes)

Vaccine

Volumn 27, Issue 17, 2009, Pages 2306-2311

  Song, Xiaoming ^a   Zang, Liming ^a   Hu, Songhua ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b Agriculture Ministry of China   (China)

Author keywords

Adjuvant; Ginseng; Ginsenoside; Ginsomes; Nanoparticles; Th1 Th2

Indexed keywords

CHOLESTEROL; GAMMA INTERFERON; GINSENG EXTRACT; GINSENG SAPONIN; GINSENOSIDE; GINSENOSIDE RB 1; GINSENOSIDE RB 2; GINSENOSIDE RC; GINSENOSIDE RD; GINSOMES; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 5; NANOPARTICLE; OVALBUMIN; PHOSPHATIDYLCHOLINE; QUIL A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG SYNTHESIS; FEMALE; IMMUNE RESPONSE; INSTITUTE FOR CANCER RESEARCH MOUSE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODY FORMATION; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; GINSENOSIDES; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-5; LYMPHOCYTE ACTIVATION; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; OVALBUMIN; PANAX; PLANT EXTRACTS; SPLEEN;

EID: 62249174378     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.02.040     Document Type: Article

References (24)

1. Kenney R.T., and Edelman R. Survey of human-use adjuvants. Expert Rev Vac 2 2 (2003) 167-188
2. Lindblad E.B. Aluminium adjuvants-in retrospect and prospect. Vaccine 22 27-28 (2004) 3658-3668
3. Gupta R.K., Relyveld E.H., Lindblad E.B., Bizzini B., Ben-Efraim S., and Gupta CK. Adjuvants-a balance between toxicity and adjuvanticity. Vaccine 11 3 (1993) 293-306
4. Gupta R.K., and Siber G.R. Adjuvants for human vaccines-current status, problems and future prospects. Vaccine 13 14 (1995) 1263-1276
5. Li C.P., and Li R.C. An introductory note to ginseng. Am J Chin Med 1 2 (1973) 249-261
6. Owen R.T. Ginseng: a pharmacological profile. Drugs Today 17 8 (1981) 343-351
7. Rivera E., Hu S., and Concha C. Ginseng and aluminium hydroxide act synergistically as vaccine adjuvants. Vaccine 21 11-12 (2003) 1149-1157
8. Hu S., Concha C., Lin F., and Persson W.K. Adjuvant effect of ginseng extracts on the immune responses to immunization against Staphylococcus aureus in dairy cattle. Vet Immunol Immunopathol 91 1 (2003) 29-37
9. Rivera E., Daggfeldt A., and Hu S. Ginseng extract in aluminium hydroxide adjuvanted vaccines improves the antibody response of pigs to porcine parvovirus and Erysipelothrix rhusiopathiae. Vet Immunol Immunopathol 91 1 (2003) 19-27
10. Rivera E., Ekholm-Petersson F., Inganas M., Paulie S., and Gronvik K.-O. The Rb1 fraction of ginseng elicits a balanced Th1 and Th2 immune response. Vaccine 23 46-47 (2005) 5411-5419
11. Sun J.H., Hu S.H., and Song X.M. Adjuvant effects of protopanaxadiol and protopanaxatriol saponins from ginseng roots on the immune responses to ovalbumin in mice. Vaccine 25 6 (2007) 1114-1120
12. Morein B., Sundquist B., Hoglund S., Dalsgaad K., and Osterhaus A. Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature 308 29 (1984) 457-460
13. ® adjuvant for antigen delivery. Adv Drug Deliv Rev 57 3 (2005) 465-474
14. Wang M.Z., Gao F.Y., and Zhang G.D. Analysis of ginseng. I. The extraction, separation and colorimetric determination of ginseng sapogenins. Acta Pharm Sinc 14 3 (1979) 215-309 (in Chinese with English abstract)
15. Lovgren-Bengtsson K., and Morein B. The ISCOMTM technology. In: O'Hagan D.T. (Ed). Vaccine adjuvants: preparation methods and research protocols. Methods in molecular medicine vol. 42 (2000), Humana Press Inc., Totowa, NJ 239-258
16. Behboudi S., Morein B., and Ronnberg. Isolation and quantification of Quillaja saponaria Molina saponins and lipids in iscom-matrix and iscoms. Vaccine 13 17 (1995) 1690-1696
17. Altman D.G. Comparing groups-continuous data. In: Altman D.G. (Ed). Practical statistics for medical research (1999), Chapman & Hall/CRC, London 179-233
18. Nord L.I., and Kenne L. Separation and structural analysis of saponins in a bark extract from Quillaja saponaria Molina. Carbohyd Res 320 1-2 (1999) 70-81
19. Guo S.J., and Kenne L. Structural studies of triterpenoid saponins with new acyl components from Quillaja saponaria Molina. Phytochemistry 55 5 (2000) 419-428
20. Tang W., and Eisenbrand G. Chinese drugs of plant origin. Chemistry, pharmacology and use in traditional and modern medicine (1992), Springer-Verlag, Berlin/Heidelberg p. 711-37
21. Liu Z.Q., Luo X.Y., Sun Y.X., Chen Y.P., and Wang Z.C. Can ginsenosides protect human erythrocytes against free-radical-induced hemolysis?. Biochim Biophys Acta 1572 1 (2002) 58-66
22. Kim D.S., Chang Y.J., Zedk U., Zhao P., Liu Y.Q., and Yang C.R. Dammarane saponins from Panax ginseng. Phytochemistry 40 5 (1995) 1493-1497
23. Feldman M., and Marini J.C. Cell cooperation in the antibody response. In: Roitt I., Brostoff J., and Male D. (Eds). Immunology. 6th edition (2001), Mosby Publications, London 131-146 [chapter 8]
24. Tizard I.R. Veterinary immunology: an introduction. 6th edition (2000), Saunders, Philadelphia